Germany backtracks on AZ COVID vaccine age restrictionGermany has decided that AstraZeneca’s COVID-19 vaccine should be approved for use in the over-65s after all, reversing Share XGermany backtracks on AZ COVID vaccine age restrictionhttps://pharmaphorum.com/news/germany-backtracks-on-az-covid-vaccine-age-restriction/
2021 market access prospects for FranceIn the latest of a suite of features looking at the biggest markets in Europe, Leela Barham takes Share X2021 market access prospects for Francehttps://pharmaphorum.com/views-analysis-market-access/2021-market-access-prospects-for-france/
AZ COVID jab efficacy debate is hindering EU’s vaccine driveThe spat between the EU and AstraZeneca over access to the company’s COVID-19 shot led to scathing remarks Share XAZ COVID jab efficacy debate is hindering EU’s vaccine drivehttps://pharmaphorum.com/news/az-covid-jab-efficacy-debate-is-hindering-eus-vaccine-drive/
How does HTA for orphan drugs differ across Europe?New research looks at the factors that speed up and slow down HTA appraisals for rare disease medicines Share XHow does HTA for orphan drugs differ across Europe?https://pharmaphorum.com/views-analysis-market-access/how-does-hta-for-orphan-drugs-differ-across-europe/
Sanofi pledges €10m to Notre Dame, but faces backlashSanofi has said that it will donate 10 million Euros to the rebuilding of Notre Dame cathedral in Share XSanofi pledges €10m to Notre Dame, but faces backlashhttps://pharmaphorum.com/news/sanofi-pledges-e10m-to-notre-dame-but-faces-backlash/
Macron’s France: advancing towards a European vision for healthcare?What will Macron’s government mean for healthcare in his country and Europe? Share XMacron’s France: advancing towards a European vision for healthcare?https://pharmaphorum.com/views-and-analysis/macron-healthcare-france-europe/